heart valve disease |
Disease ID | 1589 |
---|---|
Disease | heart valve disease |
Integrated Phenotype | (Waiting for update.) |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:4) |
Disease ID | 1589 |
---|---|
Disease | heart valve disease |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | (Waiting for update.) |
Manually Genotype(Total Text Mining Genotypes:0) |
---|
(Waiting for update.) |
All Snps(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Annotation(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:0) |
---|
(Waiting for update.) |
Mapped by homologous gene(Total Items:0) |
---|
(Waiting for update.) |
Chemical(Total Drugs:7) | |||||||||
---|---|---|---|---|---|---|---|---|---|
CUI | ChemicalName | ChemicalID | CasRN | DiseaseName | DiseaseID | DirectEvidence | PubMedIDs | ||
C0018824 | cabergoline | C047047 | 81409-90-7 | heart valve diseases | MESH:D006349 | marker/mechanism | 15197703 | ||
C0018824 | cyclophosphamide | D003520 | 50-18-0 | heart valve diseases | MESH:D006349 | marker/mechanism | 1285674 | ||
C0018824 | dicloxacillin | D004009 | 3116-76-5 | heart valve diseases | MESH:D006349 | marker/mechanism | 10622550 | ||
C0018824 | fenfluramine | D005277 | 458-24-2 | heart valve diseases | MESH:D006349 | marker/mechanism | 10490797 | ||
C0018824 | methysergide | D008784 | 361-37-5 | heart valve diseases | MESH:D006349 | marker/mechanism | 10617681 | ||
C0018824 | phentermine | D010645 | 122-09-8 | heart valve diseases | MESH:D006349 | marker/mechanism | 10490797 | ||
C0018824 | thalidomide | D013792 | 50-35-1 | heart valve diseases | MESH:D006349 | marker/mechanism | 17652228 |
FDA approved drug and dosage information(Total Drugs:0) | |
---|---|
(Waiting for update.) |
FDA labeling changes(Total Drugs:0) | |
---|---|
(Waiting for update.) |